IP Verse

Botulinum Toxin Prefilled Container - EP3236939

The patent EP3236939 was granted to Merz Pharma on Aug 28, 2024. The application was originally filed on Dec 22, 2015 under application number EP15823134A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3236939

MERZ PHARMA
Application Number
EP15823134A
Filing Date
Dec 22, 2015
Status
Patent Maintained As Amended
Jul 26, 2024
Grant Date
Aug 28, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALLERGANDec 31, 2020KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORFADMISSIBLE

Patent Citations (23) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS2007134199
EXAMINATIONWO0015245
EXAMINATIONWO2006005910
EXAMINATIONWO2009008595
INTERNATIONAL-SEARCH-REPORTKR100753765B
INTERNATIONAL-SEARCH-REPORTUS2006269575
INTERNATIONAL-SEARCH-REPORTUS2008045889
INTERNATIONAL-SEARCH-REPORTUS2013211344
INTERNATIONAL-SEARCH-REPORTUS2014249484
INTERNATIONAL-SEARCH-REPORTWO2014026161
OPPOSITIONEP1491205
OPPOSITIONEP2311512
OPPOSITIONUS2007134199
OPPOSITIONUS2010216667
OPPOSITIONUS2014249484
OPPOSITIONWO2005032627
OPPOSITIONWO2006005910
OPPOSITIONWO2009003010
OPPOSITIONWO2010096134
OPPOSITIONWO2013066866
OPPOSITIONWO2014014641
OPPOSITIONWO2014052792
OPPOSITIONWO2016066821

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- anonymous, "Gx® Syringe Systems", Gerresheimer Brochure, (20141000), pages 1 - 20
OPPOSITION- anonymous, "Gx® Syringe Systems", Gerresheimer Brochure, (20141000), pages 1 - 20, XP055784135
OPPOSITION- Dermatol Surg 2003; 29(5): 523-529
OPPOSITION- Glen A. Thorpe et al., "Prefilled Syringes", ONdrugDelivery, (20050000), XP055784142
OPPOSITION- Patty H. Kiang, "Future Materials for Prefilled Syringe Components", American Pharmaceutical Review, (20110701), URL: https://www.americanpharmaceuticalreview.com/Featured-Articles/37276-Future-Materials-for-Prefilled-Syringe-Components/, XP003031216
OPPOSITION- Tibor Hlobik, "Enhacing Prefilled Syringe component quality...by design", ONdrugDelivery, (20140200), no. 47, XP055784147
OPPOSITION- Unilife and Datwyler, "Prefilled Syringes", ONdrugDelivery, (20110000), XP055784155
OPPOSITION- Reepmeyer John C. et al, "Contamination of Injectable Solutions with 2-Mercaptobenzothiazole Leached from Rubber Closures", J. Pharm. Sci., (19831100), vol. 72, no. 11, pages 1302 - 1305, XP055784137
OPPOSITION- Wohlfarth K. et al, "Pharmacokinetic Properties of Different Formulations of Botulinum Neurotoxin Type A", Movement Disorders, (20040300), vol. 19, no. Suppl 8, pages S65 - S67, XP055782726
OPPOSITION- Gregory A. Sacha et al, "Practical fundamentals of glass, rubber, and plastic sterile packaging systems", Pharmaceutical Development and Technology, (20100000), vol. 15, no. 1, pages 6 - 34, XP008170814

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents